Literature DB >> 23889902

Keloidal basal cell carcinoma: should it be considered a distinct entity?

Riccardo Balestri1, Cosimo Misciali, Clementina Zampatti, Giulia Odorici, John Anthony Balestri.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23889902     DOI： 10.1111/ddg.12168

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN： 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  3 in total

1.  Hyperbaric oxygen therapy improves the effect of keloid surgery and radiotherapy by reducing the recurrence rate.

Authors:  Ke-Xin Song; Shu Liu; Ming-Zi Zhang; Wei-Zhong Liang; Hao Liu; Xin-Hang Dong; You-Bin Wang; Xiao-Jun Wang
Journal:  J Zhejiang Univ Sci B       Date:  2018 Nov.       Impact factor: 3.066

2.  Keloid-derived keratinocytes acquire a fibroblast-like appearance and an enhanced invasive capacity in a hypoxic microenvironment in vitro.

Authors:  Xiaoyang Ma; Jia Chen; Bei Xu; Xiao Long; Han Qin; Robert Chunhua Zhao; Xiaojun Wang
Journal:  Int J Mol Med       Date:  2015-03-13       Impact factor: 4.101

3.  Cutaneous basal cell carcinoma arising within a keloid scar: a case report.

Authors:  Maya Goder; Rachel Kornhaber; Daniele Bordoni; Eyal Winkler; Josef Haik; Ariel Tessone
Journal:  Onco Targets Ther       Date:  2016-08-02       Impact factor: 4.147
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.